New Medical Insights from LexisNexis Health Intelligence Helps Life Insurers Expand Accelerated Programs, Mitigate Mortality Slippage and Improve Customer Experience
Launch of Medical Insights: LexisNexis Risk Solutions has introduced Medical Insights from LexisNexis Health Intelligence, a tool that standardizes and extracts critical data from electronic health records (EHRs) to enhance life insurance underwriting processes.
Key Features and Benefits: The platform offers features like Clinical Screener and Impairment Identifier, which help underwriters quickly assess health risks, improve decision-making speed, and maintain more applicants in accelerated programs while mitigating misrepresentation risks.
Trade with 70% Backtested Accuracy
Analyst Views on RELX
About RELX
About the author

- Dividend Increase: RELX PLC raises its dividend from last year's payment to £0.48, resulting in an annual yield of 3.0%, which is above the average for most companies in the industry, indicating strong performance in dividend distribution.
- Earnings Coverage: The latest dividend is easily covered by RELX's earnings, with projected earnings per share expected to rise by 40.2% over the next year, suggesting a payout ratio could reach 45% by next year, demonstrating sustainable dividend capacity.
- Stable Dividend Record: Over the past decade, RELX's annual payment has increased from £0.26 to £0.675, reflecting an average annual growth rate of about 10%, showcasing the company's stability and growth potential in dividends, which attracts more investor interest.
- Strong Income Stock: The combination of RELX's dividend growth and a 12% annual increase in earnings per share makes it a compelling income stock, allowing investors to anticipate stable cash flows and ongoing returns.
- Financial Performance: RELX reported FY 2023 revenue of £9.59 billion, up 1.4% from £9.434 billion in FY 2022, demonstrating the company's stability and resilience in the market.
- Profitability Improvement: The adjusted earnings per share (EPS) rose to 128.5 pence, a 5.8% increase from 120.1 pence the previous year, reflecting successful cost control and operational efficiency.
- Market Reaction: Despite revenue and profit growth, analysts express caution regarding enterprise software stocks, suggesting that AI impacts may accelerate market volatility, leading to potential downside pressure on RELX shares.
- Investment Rating: Analysts maintain a 'Hold' rating on RELX, indicating confidence in its long-term growth potential, particularly in the evolving technological landscape.
- Software Sector Hit: The iShares Tech-Expanded Software Sector ETF (NYSE:IGV) has plummeted nearly 20% year-to-date, making it the worst-performing industry, as fears mount that AI tools could disintermediate traditional software providers, causing forward P/E ratios for application software to drop from 35.3 to 23.7 and systems software from 35.5 to 23.3, reflecting market concerns over future earnings durability.
- Brokerage Pressure: Investment banks and brokerage firms are under pressure following the rollout of AI tools by fintech firm Altruist, with forward P/E ratios declining from 24.7 to 15.9, as the market fears that AI could replace traditional advisors in the future, leading to long-term margin compression.
- Insurance Broker Anxiety: Insurance brokers are facing disruption due to the integration of AI-driven tools, with the S&P Insurance Brokers industry index down 4% year-to-date; while the insurance sector remains relationship-driven, there are concerns that AI could erode commissions, impacting brokers' income stability.
- Asset Management Damage: Alternative asset managers are indirectly affected by significant exposure to private software companies, with many large firms down double digits year-to-date, as declining public software valuations raise concerns about their private portfolios, shrinking exit opportunities.

Impact on Professions: The rise of artificial intelligence is shifting job security concerns from software developers to lawyers, highlighting the expanding influence of AI across various professions.
Market Reactions: This transition is contributing to a rotation in the stock market, affecting both U.S. equities and international markets as investors respond to the implications of AI advancements.
- AI's Impact on Stock Market: The anticipated positive influence of artificial intelligence on the stock market has not materialized as expected.
- Market Performance: Despite initial optimism, stock market performance has been lackluster, raising questions about the actual benefits of AI in trading.
- Investor Sentiment: Investor confidence appears to be wavering as the promised AI-driven gains fail to materialize.
- Future Outlook: Analysts are reconsidering the role of AI in financial markets, suggesting a more cautious approach moving forward.
- Earnings Report: Rambus reported Q4 earnings of $0.68 per share, meeting analyst consensus, while quarterly sales reached $190.2 million, exceeding the consensus estimate of $187.563 million, indicating strong sales performance despite mixed signals.
- Sales Guidance Downgrade: Despite the sales beat, Rambus issued first-quarter sales guidance below estimates, raising concerns about future growth and potentially impacting investor confidence in the company's outlook.
- Stock Price Movement: Following the earnings report, Rambus shares fell 14.2% in pre-market trading to $97.59, reflecting negative market sentiment regarding the company's future performance and possibly prompting short-term investor sell-offs.
- Overall Market Trend: While Rambus shares declined, U.S. stock futures were mostly higher, with Nasdaq 100 futures gaining around 100 points, suggesting an overall optimistic sentiment towards tech stocks, potentially influenced by the performance of other technology companies.






